H-B-Vax II
Details for H-B-Vax II vaccine and its components.
Sponsor:
Merck Sharp & Dohme (Australia)
Administration route:
Intramuscular injection
Vaccine group:
Monovalent vaccines
Registered for use from birth.
Recombinant hepatitis B vaccine
Adult formulation
Each 1.0 mL monodose vial or pre-filled syringe contains:
- 10 µg recombinant hepatitis B surface antigen (HBsAg) protein, adsorbed onto 0.5 mg aluminium hydroxide
Paediatric formulation
Each 0.5 mL monodose vial or pre-filled syringe contains:
- 5 µg recombinant HBsAg protein, adsorbed onto 0.25 mg aluminium hydroxide
Dialysis formulation
Each 1.0 mL monodose vial contains:
- 40 µg recombinant HBsAg protein, adsorbed onto 0.5 mg aluminium hydroxide
All formulations contain latex and may contain yeast proteins.
For full details, refer to the product information and consumer medicine information sheets for H-B-Vax II vaccine available on the TGA website.
Page history
Last updated:
4 June 2018
Last reviewed:
4 June 2018
Definitions
- HBsAg
- hepatitis B surface antigen
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/h-b-vax-ii.